April 1-2, 2025 | Paris, France
Scaling Digital Health across Europe and Connecting with the US Ecosystem
Bringing together start ups - investors - accelerators
For start ups ready to scale up and looking to accelerate. Come join us to learn about scaling digital health solutions across Europe and building bridges between the health innovation ecosystems of Europe and the US
Breakthrough Alliance Europe Conference 2025
What to Expect:
- Keynote addresses and panel discussions with thought leaders in digital health
- Networking opportunities to connect with leading innovators and executives
- Presentations showcasing the latest innovations in digital health, and health technology
- Executives, investors and founders from leading healthcare organizations
- In-depth discussions about global health challenges and opportunities especially in relation to scaling up in Europe and bridging the Atlantic gap
- Speed networking with entrepreneurs doing it, accelerators that can help and service providers to make it happen
Main Tracks (Subject to Change):
- Tech Bio – AI in Drug Discovery
- Digital Medtech
- Consolidation, Scaling and Aggregation of Health Technology Across Europe
- Scaling in AI Imaging and Digital Trials
- Bridging the Gap between the US and European Adoption of Healthcare Technology
- Differences and Similarities of Investability and Past Successes of Digital Solutions in Europe vs Rest of World
Speakers
Digital Health Investor
Chair
President
Chair
Alex Peluffo
Scientific AI Senior Project Leader, QuantumBlack
Valérie Paradis
Director of the APHP Medical Imaging Open Innovation HUB (SANTINEL)
Zahime RAi
Founding Investor
Alexis Bruhat
Operating Partner, DMH | CEO, WayMed.
Join Us!
Grab your Conference pass!
- Access to main conference
- Access to all HITLAB hosted networking sessions throughout conference week
- Refreshments & lunch provided each day at HITLAB main conference venue
- Preferential registration to all partner adjacent activities to main HITLAB conference (access subject to individual partner organizer capacity and registration criteria for activity)
- Access to Exhibitor Hall
- Exclusive HITLAB conference name badge
Apply to attend
Conference is complimentary but invite-only
Apply to speak
Please fill out the following form to apply
Join Us!
Grab your Conference pass!
- Access to main conference
- Access to all HITLAB hosted networking sessions throughout conference week
- Refreshments & lunch provided each day at HITLAB main conference venue
- Preferential registration to all partner adjacent activities to main HITLAB conference (access subject to individual partner organizer capacity and registration criteria for activity)
- Access to Exhibitor Hall
- Exclusive HITLAB conference name badge
Apply to attend
Conference is complimentary but invite-only
Agenda
Chair, Day 1
9:15 AM
Doors Open / Breakfast
10:00 AM
Introduction to the Conference
10:20 AM
Keynote
Alex Peluffo, Scientific AI Senior Project Leader, QuantumBlack, McKinsey & Co
10:35 AM
Q&A
10:40 AM
TechBio: Harnessing AI to Revolutionize Drug Discovery & Development
Alex Peluffo, Scientific AI Senior Project Leader, QuantumBlack, McKinsey & Co
Dr. Olivia Geneus, Associate Director, Medical Affairs – HEOR Neuroscience, Strategy & Operations, Eli Lilly
11:00 AM
Q&A
11:10 AM
Networking Break
11:40 AM
Scale up Digital Health Companies
11:50 AM
Q&A
11:55 AM
Techbio - AI in Drug Discovery
12:00 PM
Q&A
12:05 PM
Scale up Digital Health Companies
12:25 PM
Q&A
12:30 PM
US/EUR Trends + Morning Summary
Bill Taranto, President, Merck Global Health Innovation
Laurent van Lerberghe, CEO & Founder, ballas invest
12:50 PM
Q&A
1:00 PM
Lunch & Speed Networking
2:00 PM
Scaling AI in Medical Imaging & Digital Trials: Overcoming Challenges and Driving Innovation
Baptiste Perrin, Sr Software Director at GE Healthcare
Valérie Paradis, Director of the APHP Medical Imaging Open Innovation HUB (SANTINEL)
2:20 PM
Q&A
2:30 PM
Scaling Digital Trials: Rethinking Drug Exposure in the Digital Era
Bernard Vrijens, CEO & Scientific Lead, Aardex Group
2:45 PM
Q&A
2:50 PM
Scaling Digital Clinical Trials
3:00 PM
Q&A
3:05 PM
Redefining imaging in clinical studies with the use of AI
Angel Alberich-Bayarri, CEO and founder of Quibim
3:10 PM
Q&A
3:15 PM
Networking Break
3:45 PM
Patient Care - New Approach to Quality Aging
3:55 PM
Q&A
4:00 PM
Building a Tech Stack in the Realm of Physical AI
4:10 PM
Q&A
4:15 PM
Bridging the Gap: Operationalizing AI in Clinical Data Management and Trial Execution
4:30 PM
Q&A
4:35 PM
The Economics of Healthcare: Balancing Innovation and Accessibility
Henk Joos, Investor Specialist, MEDVIA
4:55 PM
Q&A
5:05 PM
New Age Digital Medtech at Point of Care
Mehdi Benchoufi, CEO & CMO, echOpen
Olivier Defresnoye, Co-CEO, echOpen
Guillaume Laguette, CRO, echOpen
5:15 PM
Q&A
5:20 PM
Closing Panel
Bill Taranto, President, Merck Global Health Innovation
Laurent van Lerberghe, CEO & Founder, ballas invest
5:35 PM
Q&A
Chair, Day 2
Dr. Olivia Geneus, Associate Director, Medical Affairs – HEOR Neuroscience, Strategy & Operations, Eli Lilly & Company
9:15 AM
Doors Open / Breakfast
10:00 AM
Introduction Day 2
Dr. Olivia Geneus, Associate Director, Medical Affairs – HEOR Neuroscience, Strategy & Operations, Eli Lilly & Company
10:15 AM
Digital Medtech
Paul Upham, Global Head of Smart Devices at Roche / Genentech
10:35 AM
Q&A
10:40 AM
The family health app: Heloa's Evolution: Navigating the Shift to AI-led Family Care Ecosystems
Florian Le Goff, CEO, Heloa
Madhu Desbois, Director General, Heloa
10:55 AM
Q&A
11:00 AM
The Future of Universal Healthcare in Europe: Challenges and Opportunities
11:20 AM
Q&A
11:30 AM
Networking Break
12:00 PM
Scaling Across Europe: Lessons Learned From Patients Focused App
Laurent van Lerberghe, ceo & founder, ballas invest
Madhu Desbois, Director General, Heloa
12:20 PM
Q&A
12:30 PM
Scale up Digital Health Companies
12:40 PM
Q&A
12:45 PM
Morning Review
Laurent van Lerberghe, ceo & founder, ballas invest
Chrysanthi Dori, VP, Clinical Information Services, Medidata
12:55 PM
Q&A
1:00 PM
Lunch & Speed Networking
2:00PM
Differences and Similarities of Investability & Past Successes of Digital Solutions in Europe vs Rest of World
Lata Setty, Founding Investor, How Women Invest
2:10 PM
Q&A
2:15 PM
Differences and Similarities of Investability & Past Successes of Digital Solutions in Europe vs Rest of World
2:35 PM
Q&A
2:45 PM
Customer Engagement for Digital Health Innovations in the Age of AI
2:55 PM
Q&A
3:00 PM
HyprView: Unleashing the power of pathology for targeted therapies
3:10 PM
Q&A
3:15 PM
Networking Break
3:45 PM
Consolidation, Scaling and Aggregation of Health Technology Across Europe
4:05 PM
Q&A
4:15 PM
AI-AI-Oh! Bridging the Women’s Healthcare Gap, on both sides of the pond—With 24/7 AI-Powered Access
4:30 PM
Q&A
4:35 PM
Telegenz - Bridging the Digital Divide
4:45 PM
Q&A
4:50 PM
Scale up Digital Health Companies
5:00 PM
Q&A
5:05 PM
Presentation
5:15 PM
Q&A
5:20 PM
Closing Panel
Alex Pelufo, Scientific AI Senior Project Leader, QuantumBlack, McKinsey & Co
Nicolas Castoldi, Deputy Manager & Executive Director, Hotel-Dieur
Amy West, Principal Advisor, HITLAB
Dr. Olivia Geneus, Associate Director, Medical Affairs – HEOR Neuroscience, Strategy & Operations, Eli Lilly & Company
Laurent van Lerberghe, Founder & Managing Partner, KELES
5:30 PM
Q&A
Sponsors & Partners
About Hotel-Dieu
Founded in 651, Hotel-Dieu, located on Ile de la Cite at the foot of Notre-Dame de Paris, is Europe’s oldest continuously operating hospital. In 2016, AP-HP launched the New Hotel-Dieu project, aiming to open the hospital to the city and focus on the future of medicine.
Today, Hotel-Dieu is deploying an innovative medical project centered on new patient care models and multidisciplinary research at the crossroads of medical sciences, humanities, and social sciences. It builds on its history and expertise in vulnerable patients, prevention, and public health.
Since 2021, the Hotel-Dieu initiative, supported by the newly opened BioLabs incubator, has created a unique space for collaboration between healthcare professionals, researchers, and innovators.
In 2023, Hotel-Dieu became home to the first BioLabs international incubation space in France, with 1,500 m2 of offices and labs hosting 30 biotech, medtech, and healthtech startups. By 2030, 10,000 m2 will accommodate around 100 startups as part of the hospital’s transformation.
Hotel-Dieu offers a unique environment where innovators can connect with the realities of medical care and collaborate with caregivers and patients to develop the future of healthcare solutions.
About HITLAB
HITLAB is a global leader in healthcare innovation, driving the creation and adoption of transformative technologies. Through research, education, and collaboration, HITLAB empowers organizations to tackle healthcare’s biggest challenges and improve lives worldwide.